YASOO Health - Initiates Aggressive National Health Talk Radio Campaign

Johnson City, TN - Yasoo Health Inc has initiated an aggressive national ‘Health Talk’ radio advertising campaign that began September 1st. The 60 second radio ads featured five times per week on The Duke & The Doctor Show (79 National Radio Stations), twice per week on Health Talk with Dr. Bob Martin (124 National Radio Stations) and twice per week with The Deborah Ray Show/Healthy Talk Radio (51 National Radio Stations) have been designed to support sales for our Independent Health Food stores and distribution. Each of the radio programs will feature multiple interviews over a thirteen-week period with Dr. Andreas Papas, President of Yasoo Health Inc and author of The Vitamin E Factor, regarding our unprecedented science and research efforts.

This national radio advertising campaign will air 745 commercials per week featuring Yasoo Health’s Vitamin E Factor 400/400, Omega-T, and Callisto Vitamin E Crème. Within the closing few seconds of each commercial, listeners are encouraged to ask their favorite store to stock Yasoo Health products for them, call Yasoo Health at (888) 469-2766, or order online at www.Yasoo.com.

ABOUT YASOO Health - Yasoo Health (Yasoo meaning "Good Health" in Greek) is a nutraceutical company based in Nicosia, Cyprus with a U.S. office in Johnson City, TN. Yasoo Health was the first company to move into the East Tennessee State University (ETSU) Innovation Laboratory, which links entrepreneurs with investors to facilitate the creation of technology-based startup and spin-off companies. YASOO is developing proprietary technologies to create disease-specific products based on nutrients and natural Compounds that will aid in the effective management of chronic diseases and supply safe and effective formulations in highly bioavailable form to meet the specific needs of most consumers. Three Distinguished Cypriot scientists established the Company in 1998 in the United States of America.

Yasoo pioneered the Vitamin E Factor TM concept to highlight the importance of the complete Vitamin E family of 8 compounds. At the time, most commercially available Vitamin E consisted of a-tocopherol, only one of the 4 tocopherols and 4 tocotrienols that make up natural Vitamin E. Scientists are now discovering the benefits of the other members of vitamin E especially gamma-tocopherol and the tocotrienols. YASOO was the first to introduce products that contain the complete family of tocopherols plus tocotrienols in their natural form as found in our food.

The Company’s business model includes both a traditional nutritional supplement line and a proprietary, disease specific product line. The traditional nutritional supplement line includes premium nutritional supplements and a skin cream specially formulated on the basis of the latest science and clinical research to promote wellness and prevent disease. YASOO plans to expand its line of non-proprietary products to meet key market needs.

Yasoo president, Dr. Andreas Papas holds a Ph.D. in Nutritional Biochemistry and combines 25 years of academic and industrial experience in nutraceuticals. Dr. Papas is currently an Adjunct Professor at the College of Medicine at East Tennessee State University and a Senior Scientific Advisor of the Cancer Prevention Institute at Harvard’s School of Epidemiology. He is the author of The Vitamin E Factor (HarperCollins, 1999) and editor of the scientific book Antioxidant Status, Diet, Nutrition and Health (CRC Press, 1998).

Professor Kyriacos Nicolaou, YASOO Scientific Advisory Board Chairman, is Chairman of the Chemistry Department at the Scripps Research Institute in La Jolla, San Diego. Dr. Nicolaou is a well renowned authority in chemical synthesis and chemical biology with over 500 scientific publications, two books, and sixty patents. Dr Michael Nicolaou is a Vice President in Business Development of Epimmune Inc., a California-based biotechnology Company.

In July 2002, Yasoo Health received $4.6 million in venture capital financing. In 2002 Yasoo Health received a $100,000 NIH Grant for Phase I in-vitro Cystic Fibrosis research. NIH Phase II in-vivo grant funding is presently being pursued.

Current Yasoo Health research and product development includes:

An NIH grant-supported project to develop a nutritional supplement for Cystic Fibrosis patients. This proprietary nutritional supplement is specifically formulated to overcome the lipid malabsorption condition that is a characteristic of Cystic Fibrosis patients and thereby provide their daily lipid nutritional requirements

A proprietary aqueous vitamin E nutritional supplement formulation for individuals with lipid malabsorption syndromes

An omega-3 fatty acid nutritional supplement formulation to assist in the lowering of cholesterol

A line of skin care products, including a night cream, body oil, skin reparative, and hand and body lotion.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.